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100.000 to 33.750.000 HCV RNA coppies/mL. HCV genotype
were found: G1 in 19, G2 in 2, G3 in 9, G4 in 2 and mixed G
in 5 patients. Sustained viral response (SVR) was achived in
21/27 (77,77%), relapse (R) was found in 4 (14,81%) patients
and 2 patients (7,40%) were nonresponders (NR). Therapy
was deﬁnitly interrupted in only one patient. We had to stop
treatment temporaly and to reduse dose of antiviral drugs
in 10 (27%) patients. Adverse effects of therapy were found
in 30 (81,1%) patients
Conclusions: Treatment of CHC in IDUs was successful and
it shows that more IDUs should be treated with antiviral
therapy.
doi:10.1016/j.ijid.2008.05.1094
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Background: It is known that the nosocomial viral hepati-
tis agents Hepatitis B (HBV), Hepatitis D (HDV), and Hepatitis
C (HCV) viruses are transmitted by the close contact and
invasive procedures. The nosocomial viral hepatitis (NVH)
transmission cases were followed for last seven years period.
Materials and Methods: Between 1999 to 2006; 28 NVH
cases were followed for 12—72 months at the Research and
Application Hospital that is committed to the University. It
was taken the notice of the negative chronic viral hepatitis
markers and normal value of transaminases of the cases. The
cases that were considered of transmission of HBV, HCV, and
HDV at the outside of the hospital were excluded from the
study. All the cases were evaluated for the acute viral hep-
atitis markers for HBV, HCV and HDV, after 15th and 90th day
of the suspected transmission. The cases who were known
that transmission of HBV, HDV and HCV was occurred were
re-evaluated for the medical status of before transmission
and present.
Findings and Results: There were totally 28 cases (eigh-
teen were man, ten were women) ages between 20 to 67
were suspected of the transmission of nosocomial viral hep-
atitis. Six of them were doctors, six of them were nurses,
four of them were medical stuff and twenty were patients
that were hospitalized for another medical reason. It was
determined that all the hospital stuff had their viral hep-
atitis agent transmission because of needle-sticks and ten
of the patients had their transmission because of endo-
scopic and invasive procedures. From these 28 cases: 5
cases (four medical staff, and one patient) exposured HBV,
previously known 4 chronic hepatitis B patients exposured
nosocomial HDV transmission and 19 cases (6 doctors, 6
nurses, 7 patients) exposured nosocomial HCV transmission.
At the end of the observation; from the 4 medical stuff and
one patient who didn’t get any prophylaxis two of them
got Anti-HBs seroconversion, but the other two stuffs got
their diseases chronically HBV carriers. Four patients who
were previously known that were chronic viral hepatitis B,
acquired their HDV exposure and transmission because of the
endoscopic procedures and superinfection were occurred at
all four of them. These four HDV superinfection patients
were given interferon treatment (10 million IU/3 times a
week) for one year. After the treatment their transami-
nases decreased to the normal values and HDV-RNA of all
four patients were negative. The two of four nosocomially
HDV exposured patients had Anti-HBs seroconversion and all
four patients had negative Anti-HDV tests. After one year,
the two patients who had Anti-HBs seroconversation and got
HBsAg positivity again. HCV exposured 12 items (6 doctors,
6 nurses) got nor transaminase elevation neither Anti-HCV
or HCV-RNA positivity. From the HCV exposured 7 patients;
the two of them got spontaneous clearance, ﬁve of them got
acute HCV infection and treated for one year. But one male
patient with acute HCV infection who didn’t tolerate the
treatment got a decomposed liver disease after two years.
At one acute HCV infected female and spontaneously cleared
patient got a ﬂare of HCV infection during an immunosuppre-
sive treatment because of her temporal arteritis. The other
four patients who had received pegilated interferon treat-
ment for one year got sustained response to the treatment.
Conclusions: As a result from ﬁve nosocomial HBV infec-
tions two had a chronic hepatitis B infection. From 19
nosocomial HCV infection there was one chronical infec-
tion. From four nosocomial HDV infection were treated
successfully. The viral hepatitis agents causes chronic ill-
ness at immun compromised patients. These patients must
be evaluated for prophylaxis after a HBV exposure. Although
HCV is still an important viral pathogen for nosocomial
transmission; it makes chronic viral hepatitis that has long
progression time period at healthy people.
doi:10.1016/j.ijid.2008.05.1095
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Background: Although several blood borne viral infec-
tions are transmitted sexually, yet acquiring hepatitis C virus
(HCV) infection by this route is debated. Risk of chronicity
with HCV infection is high and increases co-morbidity when
present along with HIV in high risk groups.
Methods: We recruited 426 female sex workers (FSWs)
who consented by Respondent Driven Sampling (RDS) tech-
nique in a Linked Anonymous strategy. The respondents
provided behavioral data and biological samples. Serum
samples were tested for HIV and HCV by ELISA. To assess
the associated risk factors, samples were also tested for
HSV-2 and syphilis. Urine samples were tested for gonorrhea
and chlamydial infections by Aptima Gen probe. Data were
analyzed using SPSS 10.0 statistical software.
Results: Of the 426 FSWs enrolled, the overall anti-HCV
antibody positivity was 9.6%; 45.9% among those who were
IDUs and in 7.5% with no history of injecting drug abuse,
blood transfusion or tattooing. HIV-1 antibody was positive
in 13.6% while 2.3% had detectable HBsAg. HIV-HCV co-
infection was present in 36.2%. Among the STIs, HCV was
signiﬁcantly associated with HSV-2 in 15.5% (OR 2.9, 95%
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CI 1.5—5.5, p < 0.02). Risk of acquiring HCV infection was
found to be 1.8 times more among FSWs who had any one
STI and practiced anal sex (p≥ 0.05) and the risk increased
12.8 times in the presence of injecting drug use (p≤ 0.05).
Within the control group, HCV antibody was present in only
1% of antenatal mothers in monogamous relationship and in
0.2% of blood donors in the region.
Conclusion: HCV antibody was found among FSWs in the
absence of the established risk factors known for transmit-
ting HCV infection. Strong association with HIV and HSV-2
indicate that the presence of these infections along with
other risk factors facilitate sexual transmission of HCV in
this setting.
doi:10.1016/j.ijid.2008.05.1096
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Background: Hepatitis C virus (HCV) genotypes and sub-
types are distributed differently in different parts of the
world. HCV genotype information is important because it
can be used as a predictor of treatment response and out-
come. In this study we evaluated the genotypes of patients
with HCV in a Greek hospital.
Methods: Specimens from 61 patients (35 males and 26
females) with HCV were tested. HCV RNA viral load was
determined by PCR (Cobas AmplicorTM HCV Monitor v2.0,
Roche Molecular Diagnostics). HCV genotype and subtype
were determined by direct sequencing of the 5′ NC gene
fragment (TrugeneTM HCV 5′ NC Genotyping Kit, Siemens
Healthcare Diagnostics)
Results: Genotype 1 was present in 21 patients with most
common subtype 1b (16/21), while genotype 3 was present
in 24 patients with most common subtype 3a (23/24). Geno-
type 2 was present in 8 patients, genotype 4 in 7 and
genotype 5 in 1. In males genotype 3 was the most frequent
(19/35), while in females genotype 1 (13/26). Genotype 3
was the most frequent (43%) in patients younger than 50
years, while genotype 1 was the most frequent (47%) in those
older than 50 years. Twenty-one patients had a baseline high
viral load (above 800,000 IU/ml): six with genotype 1b, two
with 1a, ﬁve with 2, seven with 3a and one with genotype
4. High baseline viral load was observed in 37% of patients
aged less than 50 years and 42% aged over 50 years.
Conclusion: Genotypes 1 and 3 had almost equal dis-
tribution and represent together 73% among the study
population. Genotype 1 was more frequent in older patients
and genotype 3 among younger patients.
doi:10.1016/j.ijid.2008.05.1097
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Background: Chronic hepatitis B is a public health prob-
lem in China, till to now few data are available to deﬁne
psychological state of those patients, which is extremely
important to provide psychological support for them. The
aim of the study was to explore the anxiety status and inﬂu-
encing factors in patients with chronic hepatitis B for the
purpose of providing theoretical evidences to psychological
nursing.
Methods: Sixty-seven patients with chronic hepatitis B
from the First Afﬁliated Hospital of Medical College of Xa’an
JiaoTong University from June to December in 2006 were
enrolled to complete State-Trait Anxiety Inventory (STAI)
questionnaire and questionnaire of own designing; the items
include name, sex, age, occupation, course of disease, eco-
nomic position, marital status and education.
Result: Statistic analysis indicated that state anxiety and
trait anxiety of patients with chronic hepatitis B show signif-
icant increasing in comparison with Chinese average level,
SA: 42.70± 10.32, the male SA: 42.17± 10.27 (P = 0.04),
the female SA: 44.05± 10.33 (P = 0.02); TA: 44.03± 9.17,
the male TA: 43.81± 8.61 (P = 0.028), the female TA:
46.06± 8.79 (P = 0.02). Factors associated with SA include
age (P = 0.036), occupation (P = 0.034), economic position
(P = 0.000), level of received education (P = 0.001); factors
associated with of TA include marital status (P = 0.023),
economic position (P = 0.000), level of received education
(P = 0.044).
Conclusion: SA and TA are very widespread in clinic
hepatitis B patients, the common factors include age, occu-
pation, economic position, level of received education,
marital status. It is necessary for nurses to know about
patients’ psychological status and provide targeted care to
them according to inﬂuencing factors.
doi:10.1016/j.ijid.2008.05.1098
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Background: Chronic hepatitis B is a public health
problem in China, HBV infection results in approximately
280 thousand deaths per year, mainly caused by chronic
hepatitis, cirrhosis, and hepatocellular carcinoma (HCC).
Accumulating evidence has linked psychological factors to
the onset, progression, and outcome of chronic and latent
viral infection. Psychological factors modulate immune sys-
tem by initiating neuroimmune axis responses. Thus, we
